You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 3, MARCH 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

"Complete" Erythrocyte Glucose-6-Phosphate Dehydrogenase Deficiency

Nonspherocytic Hemolytic Anemia in a Caucasian Adult Associated With Neurologic Abnormalities

MIGUEL A. ESCOBAR, MD; PAUL HELLER, MD; FRANK E. TROBAUGH, JR., MD

Arch Intern Med. 1964;113(3):428-434.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Erythrocyte glucose-6-phosphate dehydrogenase (G-6-PD) deficiency, usually designated as "primaquine sensitivity," is a common genetic disorder of wide geographic and racial distribution.1,2 It occurs in 12% to 15% of male Negroes and also in certain Caucasian population groups, eg, Sephardic Jews, Sardinians, Iranians. Enzyme activity is usually not completely absent, and, therefore, persons with this abnormality are ordinarily not anemic unless hemolysis is provoked by the exposure to certain toxic and infectious agents.1,2

Complete absence of G-6-PD activity in the red cell is very rare. It has been described in children,3-5 usually of Northern European extraction, with nonspherocytic hemolytic anemia. There have been very few references 4,6 to the existence of this variant of G-6-PD deficiency in the adult. The hemolytic process due to this disorder may not become clinically manifest until adult life, and, therefore, its occurrence in the older age groups needs to be emphasized.

The . . . [Full Text PDF of this Article]


Author Affiliations

CHICAGO

Formerly Research Fellow, Section of Hematology, Department of Medicine, Presbyterian-St. Luke's Hospital (Dr. Escobar); Associate Chief of Staff for Research and Hematologist, Veterans Administration West Side Hospital, Professor of Medicine, University of Illinois College of Medicine (Dr. Heller); Director, Section of Hematology, Department of Medicine, Presbyterian-St. Luke's Hospital, Associate Professor of Medicine, University of Illinois College of Medicine (Dr. Trobaugh).

From the departments of medicine, Presbyterian-St. Luke's Hospital, Veterans Administration West Side Hospital, and the University of Illinois College of Medicine.


Footnotes

Received for publication May 27, 1963; accepted June 12.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.